Insulin Pump Market to Reach US$ 25.40 Billion By 2033 | Astute Analytica
Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...
Insulin Pen And Pump Market Expansion Forecasted At 6.97% CAGR To 60.0 Billion USD By 2032 Abbott Laboratories, Roche
Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...
Patients using diabetes apps can miss critical alerts. Here’s how to make sure you’re getting them
These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...
Gov. Ned Lamont unveils proposals to tackle prescription drug costs
There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...
The Effects Of Extreme Heat On Diabetes
Managing diabetes is even harder when temperatures and humidity are rising. Find out how extreme heat can negatively affect ...
Beta Bionics targets $114M IPO raise to fund insulin pump development
The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...
How biochemistry and molecular biology gave the world insulin
Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...
Pharmabiz1h
US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices
US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices: Maryland Friday, February 7, 2025, 09:0 ...
Medscape18h
FDA Warns About Diabetes Device Smartphone Alert Settings
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
Q&A: Diabetes care for the aging population in the digital age
Medha N. Munshi, MD, a geriatrician and endocrinologist at Beth Israel Deaconess Medical Center, has dedicated her career to ...
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Embecta raises FY2025 adjusted EBITDA margin guidance to 37% amid cost-cutting and debt reduction focus
Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...